Finally, the alterations in the levels of the targets discovered in this study were corroborated using liver specimens from patients with acute liver injury or fibrosis/cirrhosis, thus highlighting the potential applications of the Gα12-ROCK1 axis for the treatment of liver injury, and the resulting fibrosis and cirrhosis in humans. The gene discussed is ROCK1; the disease is Cirrhosis.